JAMA Medical News: Recent Episodes
JAMA Network
Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?" Related Content:
- Will New Lyme Disease Approaches Change Patient Care?
Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content:
- Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?" Related Content:
- A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace." Related Content:
- Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content:
- What to Know About the First CKM Syndrome Guidelines
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content:
- Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content:
- First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content:
- PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content:
- A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content:
- In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content:
- Inside the Push for a Fentanyl Vaccine
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content:
- HFpEF May Be a Different Disease in Patients With Severe Obesity
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content:
- A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know
Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content:
- Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal
- When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related Content:
- More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed." Related Content:
- Experts Debate How Obesity Should Be Defined and Diagnosed
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?" Related Content:
- These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics." Related Content:
- Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?" Related Content:
- Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring." Related Content:
- What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer." Related Content:
- How mRNA Vaccines Could Help Treat Cancer
Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content:
- PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking." Related Content:
- New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content:
- What to Know About the New Lipid Guidelines
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content:
- Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content:
- After a Decade of Progress Against HIV, PrEP Enters a Precarious Era
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content:
- Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health." Related Content:
- In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What Nutrition Experts Say About the New Dietary Guidelines for Americans." Related Content:
- What Nutrition Experts Say About the New Dietary Guidelines for Americans
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "US Patients Getting ICE-d-Out of Health Care." Related Content:
- US Patients Getting ICEd-Out of Health Care
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis." Related Content:
- Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content:
- Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year
In this week's roundup, Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Stress May Link Depression and Anxiety to Cardiovascular Disease." Related Content:
- Stress May Link Depression and Anxiety to Cardiovascular Disease
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more. Related Content:
- What to Know About the Wegovy Pill for Obesity
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the WHO's New GLP-1 Guideline" and more. Related Content:
- What to Know About the WHO's New GLP-1 Drug Guideline
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and staff writer Samantha Anderer discuss "Can Nicotine Pouches Help People Quit Smoking?" and more. Related Content:
- Can Nicotine Pouches Help People Quit Smoking?
In this week's roundup, JAMA Medical News Associate Managing Editor Kate Schweitzer and freelance writer and Harvard medical student Emily Harris discuss "A Growing Movement Aims to Prepare All Physicians to Care for Older Adults" and more. Related Content:
- A Growing Movement Aims to Prepare All Physicians to Care for Older Adults
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content:
- Research of the Year 2025
Updates on coffee and AFib, a polypill approach for HFrEF, the first oral PCSK9 inhibitor, vitamin D supplementation for secondary prevention, and more: Joanna Chikwe, MD, chair of the American Heart Association's Scientific Sessions conference and of the Department of Cardiac Surgery in the Smidt Heart Institute at Cedars-Sinai Medical Center, shares clinical research highlights from the recent meeting. Related Content:
- Coffee and AFib, Oral PCSK9 Drugs, an HFrEF Polypill, and Vitamin D Post-MI—Highlights From AHA 2025
Correction: an earlier version of this podcast misstated the phosphorylated tau analyte measured by the Roche blood biomarker test. It is p-tau181, not p-tau217.
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use" and more. Related Content:
- Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance" and more. Related Content:
- US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance
Updates on SGLT2 inhibitors, fish oil and hemodialysis, GLP-1 drugs, and more: Katherine R. Tuttle, MD, education committee co-chair of Kidney Week 2025 and a professor of medicine at the University of Washington, shares clinical research highlights from the recent meeting. Related Content:
- SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week
In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies Under the Radar" and more. Related Content:
- Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
- MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies Under the Radar
jamamedicalnews.com
In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines" and more. Related Content:
- Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines
Dementia is still a highly stigmatized condition. Nancy Berlinger, PhD, a senior research scholar at The Hastings Center for Bioethics, discusses a new report about the cultural narratives of dementia and how they can affect the quality of life and the care of patients with the condition. Related Content:
- Living With Dementia Report Emphasizes That Even Those With Advanced Disease Have Stories to Share
State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound; Oral Microbiome Composition Linked to Pancreatic Cancer Risk Related Content:
- Oral Microbiome Composition Linked to Pancreatic Cancer Risk
- State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound
A new European Society of Cardiology clinical consensus statement deals with cardiovascular disease prevention and management in COVID-19, including cardiac long COVID. The report's lead author, Vassilios Vassiliou, MBBS, PhD, MA, discusses the guidance and key questions that remain about COVID-19 and the heart. Related Content:
- New Guidance on Cardiovascular Disease and COVID-19—From Infection to Long COVID to Vaccination
Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children’s risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content:
- Acetaminophen Use in Pregnancy—Study Author Explains the Data
Ultraprocessed Foods and Cardiometabolic Health—New Report on a “Growing Public Health Challenge”; New Analysis of Women’s Health Initiative Data Aims to “Clear the Air” Over Menopausal Hormone Therapy Related Content:
- New Analysis of Women’s Health Initiative Data Aims to “Clear the Air” Over Menopausal Hormone Therapy
- Ultraprocessed Foods and Cardiometabolic Health—New Report on a “Growing Public Health Challenge”
Updates on GLP-1 drugs in heart failure, β-blockers after myocardial infarction, the shingles vaccine, and more: Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress. Related Content:
- GLP-1 Drugs in Heart Failure, β-Blockers After MI, the Shingles Vaccine, and More From ESC 2025
Pulmonologist Michael J. Welsh, MD, is the co-recipient of the 2025 Lasker-DeBakey Clinical Medical Research Award for his research on cystic fibrosis. In this interview, he discusses his early clinical encounters with the disease, the foundational work that led to the lifesaving drug Trikafta, and future directions for cystic fibrosis treatment. Related Content:
- How Cystic Fibrosis Went From Fatal to Treatable
- Rewriting the Chapter on Cystic Fibrosis
What Is 7-OH?; Real-World Experience With Antiamyloid Therapies for Alzheimer Disease; FDA Panel on SSRIs and Pregnancy Lacked Nuance, Experts Say Related Content:
- What to Know About 7-OH, the New Vape Shop Hazard
- Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows
- FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree
The Effects of Newly Changed Guidance on COVID-19 Shots During Pregnancy; Heart Disease Deaths Have Changed; Progress Toward a Norovirus Vaccine Related Content:
- The CDC No Longer Recommends COVID-19 Shots During Pregnancy—Now What?
- New Research Finds Long-Term Shifts in Heart Disease Mortality
- Is There a Norovirus Vaccine on the Horizon?
In this follow-up to a 2017 interview with JAMA Medical News, the University of Southern California’s Maja Matarić, PhD, the computer scientist who pioneered the field of socially assistive robotics, discusses how artificial intelligence is advancing the field in areas ranging from autism to physical rehabilitation to anxiety and depression. Related Content:
- Social Robots That Help Support People’s Health Are Getting a Boost From AI
- Socially Assistive Robots
Kimmie Ng, MD, MPH, a JAMA associate editor and associate chief of the Division of Gastrointestinal Oncology at the Dana-Farber Cancer Institute, shares highlights from the American Society of Clinical Oncology’s annual meeting, including new research on diet, exercise, and cancer survival and the best time of day for treatment. Related Content:
- Lifestyle and Cancer Survival, the Best Time of Day for Treatment, and More—Highlights From ASCO
New NIH-FDA Partnership Targets Nutrition Research Gaps; First Blood Test for Alzheimer Biomarkers Receives FDA Clearance; A Growing Movement to Care for Caregivers Related Content:
- New Federal Program Seeks to Bridge Nutrition Research With Regulatory Policy
- What to Know About the First FDA-Cleared Blood Test for Alzheimer Biomarkers
- As the US Ages, a Growing Movement Aims to Care for Caregivers
Delaying diagnosis of parkinsonism can mean delaying care. In a study recently published in JAMA Neurology, David Vaillancourt, PhD, and colleagues tested the ability of an AI model to differentiate between Parkinson disease and other neurodegenerative disorders when paired with MRI. He joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH to discuss. Related Content:
- A Large Proportion of Parkinson Disease Diagnoses Are Wrong—Here’s How AI Could Help
- Automated Imaging Differentiation for Parkinsonism
Federal Funds for Rural Health Care May Be Cut; Why the IV Fluid Shortage After Hurricane Helene Was Years in the Making; Surge in US Sports Betting Raises Public Health Concerns Related Content:
- Federal Funds for Rural Health Care Are on the Chopping Block—Here’s What That Could Mean
- IV Fluid Shortages Persist Months After Hurricane Helene Hit a Supplier—Hospitals Have Had to Adapt
- The Hidden Health Costs Associated With Legalized Sports Gambling
Susan Athey, PhD, of Standford University joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss her research on machine learning to target behavioral nudges for college students and their potential implications for health care. Related Content:
- How an Economist’s Application of Machine Learning to Target Nudges Applies to Precision Medicine
Axe Falls on Federal Health Workforce; Experts Say CDC Cuts Will Cost Lives Related Content:
- “Guaranteed Pandemonium” as HHS Secretary Slashes Federal Health Workforce
- Experts Say Abrupt and “Staggering” CDC Cuts Will Cost Lives
Ajay J. Kirtane, MD, SM, a professor of medicine at Columbia University Irving Medical Center, discusses late-breaking clinical research presented at the annual meeting of the American College of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Related Content:
- Heart Health Highlights From ACC—Marathon Runners and Mortality, Oral GLP-1 Drugs, and More
Diabetic retinopathy remains a leading cause of preventable blindness worldwide, and AI may facilitate screening, if such models continue to perform well when they are deployed in the real world. Coauthors Arthur Brant, MD, of Stanford University, and Sunny Virmani, MS, of Google join JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a new study published in JAMA Network Open. Related Content:
- Diabetic Retinopathy Is Massively Underscreened—an AI System Could Help
- Performance of a Deep Learning Diabetic Retinopathy Algorithm in India
A recent study published in JAMA Health Forum suggests that institutions may be able to deploy custom open-source large language models (LLMs) that run locally without sacrificing data privacy or flexibility. Coauthors Thomas A. Buckley, BS, and Arjun K. Manrai, PhD, from the Department of Biomedical Informatics at Harvard Medical School join JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss. Related Content:
- Can Open-Source AI Models Diagnose Complex Cases as Well as GPT-4?
Correction: This podcast has been updated to add additional context on the frequency of false positives. Open neural tube defects affect approximately 1 in 1400 births. Daniel Herman, MD, PhD, of the University of Pennsylvania Perelman School of Medicine joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a quality improvement study examining the need to continue to incorporate race in tests that screen for these defects. Related Content:
- Study Findings Question Value of Including Race in Prenatal Screening for Birth Defects
- Reassessing the Inclusion of Race in Prenatal Screening for Open Neural Tube Defects
The US Is Suing Pharmacies for Aiding in the Opioid Crisis; Texas Measles Outbreak Spurs Call for Stronger Vaccine Advocacy; Study Finds Sleep-Related Infant Deaths Are on the Rise Related Content:
- US Government Sues Pharmacy Chains CVS and Walgreens for Their Alleged Role in the Opioid Epidemic
- Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy
- Amid Decreasing Infant Mortality, Sleep-Related Infant Deaths Are on the Rise
Artificial intelligence (AI) in health care is advancing, despite concerns about how its use may impact health disparities. Dimitri Christakis, MD, MPH, chief health officer at Special Olympics, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss AI’s potential role in improving health care delivery for people with intellectual and developmental disabilities. Related Content:
- How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities
- How Artificial Intelligence Can Promote Inclusive Health
A recent study showed AI-assisted screening using a large language model tool reduced time to determine trial eligibility compared with manual methods. Author Alexander J. Blood, MD, MSc, cardiologist at Brigham and Women's Hospital, and Associate Director of the Accelerator for Clinical Transformation Research Group at Harvard Medical School joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss this topic and more. Related Content:
- Study Finds AI Can Quickly Prescreen Patients for Clinical Trials, Speeding Enrollment
- Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models—A Randomized Clinical Trial
In a recent study published in JAMA Psychiatry, researchers reported that a machine learning model was able to stratify risk for subsequent diagnosis of schizophrenia or bipolar disorder among individuals already receiving psychiatric treatment. Coauthor Søren Dinesen Østergaard, PhD, of Aarhus University in Denmark joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss. Related Content:
- Machine Learning Model Shows Promise in Early Detection of Serious Mental Illness
- Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning
A recent report from the Engineering Research Visioning Alliance emphasizes the urgent need for engineering-directed research to mitigate the growing threat of antimicrobial resistance. Anita Shukla, PhD, a professor of engineering at Brown University, discusses its findings with JAMA Medical News Associate Managing Editor Kate Schweitzer and presents several key opportunities. Related Content:
- Five Engineering Advancements That May Help Solve the Growing Threat of Antimicrobial Resistance
AI can play a role in addressing language barriers in health care. In a recent Editorial in JAMA Network Open, Pilar Ortega, MD, MGM, of the University of Illinois College of Medicine, and coauthors emphasized the urgent need for integrating language equity into digital health solutions. Dr Ortega joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss. Related Content:
- Researcher Proposes New Framework for Language Equity in Health Technology
- Language Equity in Health Technology for Patients With Non–English Language Preference
- Challenges to Video Visits for Patients With Non–English Language Preference
Changes to CDC’s Website Threaten Patients, Public Health; Landmark Study of Black Women and Cancer Launches Related Content:
- As Missing and Altered CDC Webpages Threaten Patient Care, Efforts Grow to Fill Information Gaps
- Landmark Study Aims to Enroll 100 000 Black Women to Investigate Their Cancer Risks and Outcomes
Lung ultrasound aids in the diagnosis of patients with dyspnea but requires technical proficiency for image acquisition. Cristiana Baloescu, MD, MPH, of Yale School of Medicine, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss a new study published in JAMA Cardiology evaluating the ability of AI to guide acquisition of diagnostic-quality lung ultrasound images by trained health care professionals. Related Content:
- AI-Guided Lung Ultrasounds Could Help Nonexpert Clinicians Acquire “Expert-Level” Images
- Artificial Intelligence–Guided Lung Ultrasound by Nonexperts
A recent study in JAMA Network Open evaluates the use of machine learning algorithms to assess the management of urinary tract infection (UTI). Author Sanjat Kanjilal, MD, MPH, professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Healthcare Institute, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss this topic and more. Related Content:
- Researchers Use Machine Learning to Put Older Clinical Guidelines to the Test
- Use of Machine Learning to Assess the Management of Uncomplicated Urinary Tract Infection
Digital health technologies, including patient portals, are widely used by older adults, as described in a recent study published in JAMA Network Open. Author Cornelius James, MD, of the University of Michigan joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss the study and how it fits with his own experience in the clinic. Related Content:
- Study Finds Most Older Adults Use Digital Health Technologies, Plus Some Surprises
- Use of Digital Health Technologies by Older US Adults
Weight-Loss Drugs Are Reshaping the Future of Bariatric Surgery; Are Compounded GLP-1 Drugs Safe? Will Renaming Some Cancers as Noncancers Hurt or Help? Related Content:
- What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?
- Patients Are Flocking to Compounded Weight-Loss Drugs, but Are They Safe?
- Experts Are Debating Whether Some Cancers Shouldn’t Be Called That
How do patients feel about the quality of AI-generated responses to their messages to clinicians? Author Eleni Linos, MD, DrPH, of Stanford joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss her recent study in JAMA Network Open that characterized satisfaction with these messages. Related Content:
- Study Finds People Prefer AI Over Clinician Responses to Questions in the Electronic Medical Record
- Perspectives on Artificial Intelligence–Generated Responses to Patient Messages
The burden of responding to clinician inbox messages may be a contributor to burnout. Eden English, MD, of UCHealth joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss her recent study published in JAMA Network Open, which examined the use of large language models to reply to patient messages. Related Content:
- Researchers Tested an AI Tool That Drafts Responses to Patient Messages—Here’s What They Found
- Utility of Artificial Intelligence–Generative Draft Replies to Patient Messages
- Are Artificial Intelligence–Generated Replies the Answer to the Electronic Health Record Inbox Problem?
With accelerating global adoption of AI, countries are developing ethical AI frameworks to prevent harm to the most vulnerable populations. Maria Villalobos-Quesada, PhD, from the National eHealth Living Lab (NeLL) in the Netherlands and the Observatory of Bioethics and Law of the University of Barcelona, discusses this and more with JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH.
*Author image and affiliations updated February 4, 2025. Related Content:
- Study Finds Limited Evidence to Support More Than 40 Predictive Machine Learning Algorithms Used in Primary Care
- Availability of Evidence for Predictive Machine Learning Algorithms in Primary Care
- The Need for Continuous Evaluation of Artificial Intelligence Prediction Algorithms
American Indian and Alaska Native communities have higher rates of suicide than any other racial or ethnic group in the US. A recent study published in JAMA Network Open describes an AI-based suicide screening tool investigated in an American Indian community. Author Emily Haroz, PhD, of Johns Hopkins Bloomberg School of Public Health, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH. Related Content:
- How AI Could Help Clinicians Identify American Indian Patients at Risk for Suicide
- Performance of Machine Learning Suicide Risk Models in an American Indian Population
How can hospitals use early warning score tools to risk stratify patients without adding to alarm fatigue? Dana Edelson, MD, MS, of the University of Chicago joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a recent study published in JAMA Network Open that she coauthored, comparing 6 early warning scores designed to recognize clinical deterioration in hospitalized patients. Related Content:
- Researchers Compared Hospital Early Warning Scores for Clinical Deterioration—Here’s What They Learned
- Early Warning Scores With and Without Artificial Intelligence
Why COVID-19 Vaccines Don’t Stop Transmission; Hospital-at-Home—But Make It Virtual Related Content:
- In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission
- The Next Step in Hospital-at-Home Care Could Be Virtual
Chatbots may have a role in enhancing clinical care, but the best way to apply them remains a work in progress. Jonathen Chen, MD, PhD, and Ethan Goh, MD, MS, of Stanford, join JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss their randomized clinical trial published in JAMA Network Open investigating the use of chatbots in clinical practice. Related Content:
- An AI Chatbot Outperformed Physicians and Physicians Plus AI in a Trial—What Does That Mean?
- Large Language Model Influence on Diagnostic Reasoning
In a recent Viewpoint published in JAMA, Michael Pencina, PhD, of Duke University, argued for a federated registration system for AI tools deployed in health systems. He joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss his article, the Coalition for Health AI (CHAI), and more. Related Content:
- Health Systems Are Struggling to Keep Up With AI—A National Registration System Could Help
- A Federated Registration System for Artificial Intelligence in Health
Cardiologist Amit Khera, MD, chair of the American Heart Association’s recent flagship meeting, discusses some of the most important clinical studies presented at the conference with JAMA Medical News Director Jennifer Abbasi. They touch on antiobesity drugs, new compounds to reduce lipoprotein(a), AI tools, and more. Related Content:
- Lp(a) Reduction, GLP-1s for Heart Failure, and More—Highlights From the AHA Scientific Sessions
In resource-limited settings, an integrated AI tool allows novice users to improve gestational age estimates. Jeffrey Stringer, MD, University of North Carolina, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss "Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps." Related Content:
- The Low-Cost, Battery-Powered AI-Enabled Ultrasound Device That Could Improve Global Obstetric Care
- Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps
Effective communication is essential in medicine, yet language barriers can result in suboptimal care. AI holds promise for bridging these gaps, enhancing outcomes, and reducing disparities. Casey Lion, MD, MPH, from the University of Washington School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss AI as an interpreter in the clinic. Related Content:
- Researcher Explores Using AI to Overcome Language Barriers With Patients
- Artificial Intelligence for Language Translation
How Antibiotic Underuse Is Driving Antimicrobial Resistance; What to Know About the XEC SARS-CoV-2 Variant Related Content:
- UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver
- What to Know About XEC, the New SARS-CoV-2 Variant Expected to Dominate Winter’s COVID-19 Wave
A recent Special Communication published in JAMA points out that the FDA has already approved nearly 1000 devices using AI. Author Robert M. Califf, MD, commissioner of the US Food and Drug Administration, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss AI regulation. Related Content:
- FDA Commissioner Robert Califf on Setting Guardrails for AI in Health Care
- JAMA AI Interview With Robert M. Califf, MD
- FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it's also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in managing decision-making in cardiac care. Related Content:
- AI Can’t Worry About Patients, and a Clinical Ethicist Says That Matters
- Echoes of Concern—AI and Moral Agency in Medicine
Widespread adoption of AI raises questions about accountability, transparency, and reproducibility. Marcia McNutt, PhD, president of the National Academy of Sciences, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss advancing scientific knowledge in the age of AI. Related Content:
- National Academies President on How to Use Generative AI Responsibly in Scientific Research
Researchers Are Exploring the Role of Shingles—and a Protective Role of Shingles Vaccine—in Dementia; Could the Body Roundness Index One Day Replace BMI? Related Content:
- Researchers Are Exploring the Role of Shingles—and a Protective Role of Shingles Vaccine—in Dementia
- Could the Body Roundness Index One Day Replace the BMI?
Getting genuinely useful new technologies, from wearables to clinical decision support, into the clinic has proven to be surprisingly challenging. Tanzeem K. Choudhury, PhD, of Cornell Tech joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss how to take research into the real world in a way that is scalable and affordable. Related Content:
- How Health and Technology Sectors Can Collaborate on Better AI-Assisted Wearables
What hard lessons did the US Department of Veterans Affairs (VA) learn in 3 decades of EHR development, and what can it teach us about building better AI in medicine? Stephen Fihn, MD, MPH, of the University of Washington, and formerly a leader in the VA’s EHR efforts, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss his experience at the VA building decision support tools and other technology. Related Content:
- The VA Was an Early Adopter of Artificial Intelligence to Improve Care—Here’s What They Learned
- Hello, World—Introducing JAMA+ AI
European Society of Cardiology Vice President Carlos Aguiar, MD, discusses clinical research highlights from the largest scientific meeting in cardiovascular medicine, held recently in London. Updates include semaglutide findings, hypertension triple pills, and more. Related Content:
- Semaglutide Updates, Hypertension Triple Pills, and More—Heart Health Highlights From ESC Congress
Related Content:
- The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits
- New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19
Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, are the recipients of the 2024 Lasker-Bloomberg Public Service Award for their decades of work on AIDS in Africa. The infectious diseases epidemiologists recently reflected on their life’s work in a conversation with JAMA Deputy Editor and infectious diseases physician Preeti Malani, MD, MSJ. Related Content:
- Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award
- AIDS in Africa—Impact of Research
Extreme heat and its health outcomes are becoming more common. Jeremy Hess, MD, MPH, an emergency medicine physician and professor at the University of Washington, and Andrew Phelps, former director of the Oregon Department of Emergency Management, join Jennifer Abbasi, director of JAMA Medical News, to discuss lessons learned from the unprecedented heat wave in June 2021. Related Content:
- As Extreme Heat Becomes More Common, the Unprecedented Pacific Northwest Heat Dome Offers Lessons
Here’s What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Related Content:
- As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here’s What to Know
- Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth
Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, cochairs of the 2024 Alzheimer’s Association International Conference, speak with JAMA Medical News Lead Senior Staff Writer Rita Rubin, MA, about highlights from the annual meeting, including a blood test for Alzheimer disease, repurposing of a GLP-1 receptor agonist, and the possible brain risk from inhaling wildfire smoke. Related Content:
- A Blood Test for Alzheimer Disease, Repurposing GLP-1s, and Wildfire Smoke—Highlights From the AAIC
Social media is the focus of the US surgeon general's conversation with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. She interviews Vivek H. Murthy, MD, MBA, to discuss the dangers of social media on youth mental health, highlighting its contribution to the epidemic of loneliness. This is part 2 of a 2-part Q&A. Related Content:
- US Surgeon General Vivek Murthy: To Protect Adolescents, Social Media Needs Warning Labels
- Social Media Needs Warning Labels: Q&A With Surgeon General Vivek H. Murthy, MD, MBA
- US Surgeon General Vivek Murthy: Firearm Violence Is a Public Health Crisis
- Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
- Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
Which Variant Will Updated COVID-19 Vaccines Target This Fall? COVID-19 May Protect Against the Common Cold Related Content:
- Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky
- COVID-19 May Protect Against the Common Cold—Here’s Why Knowing That Could Lead to Better Vaccines
Endocrinologist Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, “game-changing” diabetes technologies, and a new use for a familiar drug. Related Content:
- New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions
This is a 2-part Q&A series with the US Surgeon General. In part 1, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Vivek H. Murthy, MD, MBA, to discuss the issue of gun violence as a pressing public health crisis and the critical role of public health leadership in combating this issue. Related Content:
- US Surgeon General Vivek Murthy: Firearm Violence Is a Public Health Crisis
- Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis
Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor, and guests share JAMA Network highlights from the American Society of Clinical Oncology’s annual meeting, including new research on colorectal cancer screening, an antibody therapy for non–small cell lung cancer, access to oncology clinical trials, and a new model of palliative care for patients with cancer. Related Content:
- Refining Colon Cancer Screening, Antibody Therapy for Lung Cancer, and More—Highlights From ASCO 2024
Can data from wearable devices and electronic health records enhance quality improvement in health care? In this Q&A, Sachin Kheterpal, MD, MBA, the University of Michigan Medical School Associate Dean for Research Information Technology, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the potential of data from mobile devices to revolutionize patient care. Related Content:
- Tapping AI’s Strengths—From Operating Room Safety to Wearable Device Interpretation
Multiple Factors Have Contributed to the Comeback of Syphilis in the US; How Statin Eligibility Could Change With the New CVD Risk Calculator Related Content:
- Syphilis Has Surged for Reasons That Go Beyond the Pathogen That Causes It
- New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions
Daniel Gibbs, MD, received an Alzheimer disease diagnosis 8 years ago, and in hindsight, believes the earliest symptoms appeared years before that. In this podcast, the retired neurologist speaks with JAMA Medical News lead senior staff writer Rita Rubin, MA, about how even with the neurodegenerative condition, it’s still possible to enjoy a life well-lived. Related Content:
- Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease
- A Neurologist Learned He Had Alzheimer Disease 8 Years Ago—Here’s What He Wants People to Know
College Athlete Deaths by Suicide Have Doubled; Why the Bird Flu Outbreak in Dairy Cows Matters; Combined COVID-19 and Flu Vaccines Could Be Available Next Year Related Content:
- College Athlete Deaths by Suicide Have Doubled, and Researchers Want to Know Why
- Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns
- Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available
Can AI augment radiological processes, imaging analysis, and diagnosis? In this Q&A, Saurabh Jha, MBBS, MRCS, MS, an associate professor of radiology at the University of Pennsylvania, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI could play a crucial role in improving access to medical imaging in remote, high-altitude, and low-income areas. Related Content:
- How Artificial Intelligence Will Enhance Imaging Access and Analysis
- Algorithms at the Gate—Radiology’s AI Adoption Dilemma
Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations. Related Content:
- One Day, AI Could Mean Better Mental Health for All
An Explosion of Food Is Medicine Research Could Change Health Care; Blockbuster Obesity Drugs Have Potential New Uses Related Content:
- Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
- Produce Prescriptions Sound Good, but Data to Support Them Are Lacking—That Could Soon Change
Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division. Related Content:
- Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session
Momentum Grows for Disaggregated Asian American Health Data; What Clinicians Need to Know About TikTok Related Content:
- Researchers Are Working to Disaggregate Asian American Health Data—Here’s Why It’s Long Overdue
- Patients Are Turning to TikTok for Health Information—Here’s What Clinicians Need to Know
Could generative AI assist in extending access to vulnerable populations and begin to bridge the gap in disparities? In this Q&A, Davey Smith, MD, MAS, an infectious disease specialist and virologist at the University of California, San Diego, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to explore the implications of large language models for improving patient outcomes. Related Content:
- Will Generative AI Tools Improve Access to Reliable Health Information?
Measles Is Spreading Again in the US; Questions Surround Blood Tests That Claim to Screen for Multiple Cancers; Study Provides Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Related Content:
- Measles Cases Are Spreading in the US—Here’s What to Know
- Questions Swirl Around Screening for Multiple Cancers With a Single Blood Test
- NIH Study Provides Long-Awaited Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
AI can understand brain signals linked to the sensory and motor processes involved in speech. In this Q&A, Edward Chang, MD, the chair and professor of neurosurgery at UCSF joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI has the potential to facilitate communication and how close AI development is to being able to translate human emotion. Related Content:
- Digital Avatars and Personalized Voices—How AI Is Helping to Restore Speech to Patients
Can AI enhance the speed and efficiency of interpreting ultrasounds and echocardiograms, thereby minimizing diagnostic errors? In this Q&A, Rima Arnaout, MD, a cardiologist and associate professor of medicine at the University of California-San Francisco, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the transformative impact of AI on cardiac imaging. Related Content:
- How Machine Learning Might Help Improve Cardiac Imaging
Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds Related Content:
- More Than Half of US Rural Hospitals No Longer Offer Birthing Services—Here’s Why
- When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
Automation bias and shortcuts in clinical AI models have posed significant challenges. In this Q&A, Jenna Wiens, PhD, an associate professor of Computer Science and Engineering at the University of Michigan in Ann Arbor, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how we can start leveraging human collaboration with AI to provide more effective health care. Related Content:
- Blind Spots, Shortcuts, and Automation Bias—Researchers Are Aiming to Improve AI Clinical Models
AI in clinical practice needs ethical frameworks to avert future biases. In this Q&A, Marzyeh Ghassemi, PhD, the Herman L. F. von Helmholtz Career Development Professor at MIT in Electrical Engineering and Computer Science (EECS), joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss ethical machine learning and responsible clinical implementation. Related Content:
- AI Developers Should Understand the Risks of Deploying Their Clinical Tools, MIT Expert Says
What the Latest Research Says About Paxlovid; People Are Using Potentially Dangerous “Trip-Killers” to Counter Psychedelics; Social Media Affects Youth Mental Health—Here’s What Could Help Related Content:
- Paxlovid Is Effective but Underused—Here’s What the Latest Research Says About Rebound and More
- Study Finds Hundreds of Reddit Posts on “Trip-Killers” for Psychedelic Drugs
- Social Media Industry Standards Needed to Protect Adolescent Mental Health, Says National Academies
After a Decade, Goodbye to the Pooled Cohort Equations? Experts Tackle Racial Bias in Clinical Algorithms; How COVID-19 Might Be Tied to Other Respiratory Disease Outbreaks Related Content:
- What to Know About PREVENT, the AHA’s New Cardiovascular Disease Risk Calculator
- Citing Harms, Momentum Grows to Remove Race From Clinical Algorithms
- From “Immunity Debt” to “Immunity Theft”—How COVID-19 Might Be Tied to Recent Respiratory Disease Surges
How can we leverage AI to transform health care into a more efficient model for delivering care? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Atul Butte, MD, PhD, the director of the Bakar Computational Health Sciences Institute at UCSF, to discuss scalable privilege and the need for the broad distribution of AI-driven expertise. Related Content:
- “Scalable Privilege”—How AI Could Turn Data From the Best Medical Systems Into Better Care for All
Amid the surging buzz around artificial intelligence (AI), can we trust the Al hype, and more importantly, are we ready for its implications? In this Q&A, Arvind Narayanan, PhD, a professor of computer science at Princeton, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the exploration of Al's fairness, transparency, and accountability. Related Content:
- How to Navigate the Pitfalls of AI Hype in Health Care
The Next Generation of COVID-19 Vaccines May Be Inhaled; Does Paxlovid Prevent Long COVID? Apply to the Morris Fishbein Fellowship in Medical Editing. Related Content:
- Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines
- Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID
The Morris Fishbein Fellowship in Medical Editing
Artificial intelligence holds the promise of revolutionizing disease diagnosis and prediction, but it also presents a pivotal challenge: ensuring equity. In this Q&A, Alondra Nelson, PhD, the Harold F. Linder Professor at the Institute for Advanced Study, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the equitable regulation of AI to benefit all populations. Related Content:
- How Do Policymakers Regulate AI and Accommodate Innovation in Research and Medicine?
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health, deputy director of informatics in the Altman Clinical and Translational Research Institute, and affiliate scientist in the Qualcomm Institute, all at UC San Diego, to discuss how genAI programs like ChatGPT can increase communication pathways and improve patient outcomes. Related Content:
- How AI Assistants Could Help Answer Patients’ Messages—and Potentially Improve Their Outcomes
Why Physicians Don’t Deprescribe Medicines; What to Know About Wegovy’s Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content:
- As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging
- FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
- Deciding When It’s Better to Deprescribe Medicines Than to Continue Them
JAMA Associate Editor Gregory Marcus, MD, a cardiologist and professor of medicine at the University of California San Francisco, speaks with American Heart Association Scientific Sessions 2023 conference chair Amit Khera, MD, MSc, a professor in the department of internal medicine at UT Southwestern Medical Center and the director of preventive cardiology. Related Content:
- Highlights From AHA 2023—New Risk Calculator, Semaglutide and CVD, and More
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Nigam Shah, MBBS, PhD, professor of medicine at Stanford University and chief data scientist at Stanford Health Care, to discuss how large language models are reshaping medicine and the potential pitfalls of automation. Related Content:
- Clinical AI Tools Must Be Fed the Right Data, Stanford Health Care's Chief Data Scientist Says
- Creation and Adoption of Large Language Models in Medicine
New vaccines, artificial intelligence, antimicrobial resistance, and more—JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with IDWeek 2023 cochair Col Heather Yun, USAF, MC. The infectious disease physicians discuss clinical highlights from the conference. Related Content:
- Highlights From IDWeek 2023—New Vaccines, Artificial Intelligence, and Antimicrobial Resistance
JAMA Associate Editor John M. Inadomi, MD, discusses clinical highlights from United European Gastroenterology (UEG) Week with UEG president Helena Cortez-Pinto, MD, PhD. Related Content:
- Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More
AI has potential to meaningfully improve patient care. How will AI advances help clinicians focus on the best use of their time and talents? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Suchi Saria, PhD, MSc, an associate professor in computer science at Johns Hopkins, to discuss how AI could streamline care. Related Content:
- Can Predictive AI Improve Early Detection of Sepsis and Other Conditions?
Who Should Get the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Lab? More Than 1 in 4 Nurses Say They Plan to Leave Health Care Related Content:
- Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug?
- Could Universal Donor Blood Be Made in the Laboratory?
- Overworked and Understaffed, More Than 1 in 4 US Nurses Say They Plan to Leave the Profession
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Bernard S. Chang, MD, MMSc, a neurologist and dean for medical education at Harvard Medical School, discuss how AI will change medical education, admissions, and teaching the future generation of physicians and clinicians. Related Content:
- AI Will—and Should—Change Medical School, Says Harvard’s Dean for Medical Education
- Transformation of Undergraduate Medical Education in 2023
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, talks with Andrew Bindman, MD, an internist and the executive vice president and chief medical officer for Kaiser Permanente, about AI implementation and the importance of building trust in a health care system. Related Content:
- Kaiser Permanente’s CMO: How AI Might Help Clinicians Address Patients’ Social Risk Factors
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Kedar S. Mate, MD, an internal medicine physician, President and Chief Executive Officer at the Institute for Healthcare Improvement, and faculty at Weill Cornell Medical College, to discuss AI’s role in health care quality and approaches to improving health equity. Related Content:
- New AI Tools Must Have Health Equity in Their DNA
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Kevin B. Johnson, MD, MS, the David L. Cohen and Penn Integrates Knowledge University Professor of Pediatrics, Informatics, Engineering, and Communication at the University of Pennsylvania, discuss how AI can reduce clinician burden and streamline health system functions. Related Content:
- Electronic Health Records Failed to Make Clinicians’ Lives Easier—Will AI Technology Succeed?
Should Consumers Buy a Blood Test to Evaluate Their Alzheimer Disease Risk; How Wildfire Smoke Harms Health Related Content:
- Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They?
- Raging Wildfires Are Exposing More People to Smoky Air—Here’s What That Means for Health
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Ida Sim, MD, PhD, a primary care physician and UCSF’s Chief Research Informatics Officer, discuss generative AI, large language models, and the ways in which AI could affect humanity in medicine. Related Content:
- The Promise and Pitfalls of AI in the Complex World of Diagnosis, Treatment, and Disease Management
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Michael Howell, MD, MPH, a pulmonologist and chief clinical officer at Google, to discuss the evolution of AI and what we should expect next for AI and health care. Related Content:
- Google Health’s Chief Clinical Officer Talks About Incorporating AI in Health Care
Many health care professionals are already dealing with the effects of climate change. In this Q&A, the World Health Organization’s first-ever Special Envoy for Climate Change and Health, Vanessa Kerry, MD, MSc, joins JAMA Medical News Director Jennifer Abbasi to discuss how a changing climate and extreme weather events are impacting human health, what clinicians should expect in the years ahead, and how they can help protect patients—and the planet.
Related Content:
- Critical Care Physician Takes on Climate Change in New WHO Role
- Climate Change and Health
What to Know About the First Pill Approved for Postpartum Depression; Will the Updated COVID Vaccines Protect Against the New Variant? CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant
Related Content:
- A Fast-Acting Pill Received Approval for Postpartum Depression—Is It a Game Changer?
- What to Know About EG.5, the Latest SARS-CoV-2 “Variant of Interest”
- CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant
Treating Long COVID’s Mental Health Symptoms in Primary Care; This Fall’s COVID-19 Vaccine Will Target Omicron XBB Subvariants—Who Needs to Get It; Avian Influenza Update
Related Content:
- HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID’s Mental Health Symptoms
- Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals
- This Fall’s COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen
Data on a new crop of hormone analogues for weight loss—including an oral version of semaglutide and the triple agent retatrutide—were recently presented at the American Diabetes Association’s annual Scientific Sessions. Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA’s Jennifer Abbasi about this and other clinical data presented at the meeting.
Related Content:
- New Weight Loss Drugs Make Headlines at Diabetes Meeting
The 2021 US maternal mortality rate is more than 10 times the rate of other high-income countries, according to a March 2023 CDC report. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, is joined by Monica McLemore, PhD, MPH, RN, University of Washington, Audra Meadows, MD, MPH, UC San Diego, and Joia Crear-Perry, MD, founder and president of the National Birth Equity Collaborative, to discuss these concerning numbers and why preventable death rates are worsening in the US.
Related Content:
- Trends in State-Level Maternal Mortality by Racial and Ethnic Group in the United States
- Worsening US Maternal Death Rates
- US Maternal Mortality Is Unacceptably High, Unequal, and Getting Worse—What Can Be Done About It?
- Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021
Sugar Substitutes Don’t Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns; Social Media and the Youth Mental Health Crisis
Related Content:
- Sugar Substitutes Don’t Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns
- Surgeon General Sounds the Alarm on Social Media Use and Youth Mental Health Crisis
JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting’s Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.
Related Content:
- Highlights From the ASCO Annual Meeting—New Approaches to Cancers of the Blood, Brain, Lung, and More
JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Debra Boyer, MD, MHPE, about important research studies and keynote addresses presented at the American Thoracic Society International Conference in May 2023. Dr Boyer is a pediatric pulmonologist and chief medical education officer at Nationwide Children’s Hospital in Columbus, Ohio, and was cochair of this year’s conference.
Related Content:
- COPD Mortality, Goals-of-Care Conversations in Serious Illness, and Advocating for Climate Change Science and Gun Violence Prevention—Highlights From the American Thoracic Society Conference
What Clinicians Need to Know About “Tranq”; As Laws Restricting Health Care Surge, Some US Physicians Choose Between Fight or Flight Related Content:
- As Laws Restricting Health Care Surge, Some US Physicians Choose Between Fight or Flight
- Here’s What to Know About Xylazine, aka Tranq, the Animal Tranquilizer Increasingly Found in Illicit Fentanyl Samples
- Risk of Parkinson Disease Among Camp Lejeune Veterans
JAMA Fishbein Fellow Revital Marcus, MD, talks with American Academy of Neurology president-elect and meeting science committee chair Natalia Rost, MD, about hot topics at this year’s conference in Boston, including new Alzheimer disease drugs, long COVID and the central nervous system, and a nasal spray for migraines. Related Content:
- New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines—Highlights From the 2023 American Academy of Neurology Conference
More than 14 000 infectious diseases physicians, clinical microbiologists, and public health professionals gathered in Copenhagen, Denmark, in April for the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Europe’s largest infectious diseases conference. In this Medical News Q&A, JAMA Deputy Editor Preeti N. Malani, MD, MSJ, discusses highlights from the congress with Jacob Moran-Gilad, MD, MPH, ECCMID program director. Related Content:
- Artificial Intelligence, Emerging Threats, and Diagnostic Advances—Highlights From ECCMID, Europe’s Largest Infectious Disease Conference
As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss; Implementation Science Seeks to Translate Research Into Practice; What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis Related Content:
- As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss
- It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up
- What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis
Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn’t Become Law; The Debate Over Whether to Make Daylight Saving or Standard Time Permanent; Expanded Family Leave Policies May Ease Burden for Residents Related Content:
- Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn’t Become Law
- Groundswell Grows for Permanent Daylight Saving Time, but Medical Societies Overwhelmingly Support Year-Round Standard Time
- Expanded Family Leave Policies May Ease Burden for Residents
- Cut Calories, Lengthen Life Span? Randomized Trial Uncovers Evidence That Calorie Restriction Might Slow Aging, but Questions Remain
- Highlights From the American College of Cardiology’s 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More
- Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C
JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Douglas Drachman, MD, about late-breaking research discussed at the annual conference of the American College of Cardiology and World Congress of Cardiology. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division. Related Content:
- Highlights From the American College of Cardiology’s 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More
More than 2 million individuals in the US are chronically infected with hepatitis C, and nearly 15 000 die every year. Antivirals are available but are not reaching the majority of infected individuals. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Francis S. Collins, MD, PhD, discuss a plan to eliminate hepatitis C included in the Biden-Harris 2024 budget proposal. Related Content:
- A National Hepatitis C Elimination Program in the United States
- Eliminating Hepatitis C in the United States
- Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C
- Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C
- After 12 Years, NIH Director Francis S. Collins, MD, PhD, Seeks His Next Chapter
- After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter
Conference clinical cochair Diane Havlir, MD, a professor of medicine at the University of California, San Francisco, sits down with JAMA Deputy Editor Preeti Malani, MD, MSJ, about research highlights presented at the 30th annual CROI, held in Seattle. The infectious disease experts discuss postexposure prophylaxis for sexually transmitted infections, a new protease inhibitor for COVID-19, goals for preventing HIV transmission, and more. Related Content:
- Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections—Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More
Bird Flu Has Begun to Spread in Mammals—Here’s What’s Important to Know; Questions Remain About What Should Go Into Annual COVID-19 Vaccines; Long COVID Linked With Unemployment in New Analysis; As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest. Related Content:
- Bird Flu Has Begun to Spread in Mammals—Here’s What’s Important to Know
- Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA
- Long COVID Linked With Unemployment in New Analysis
- As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest
We’re revisiting this 2017 episode—with updates! The episode is an interview with Robert T. "Chip" Schooley, MD, a professor of medicine in the Division of Infectious Diseases and Global Public Health at the University of California, San Diego, and codirector of the school’s Center for Innovative Phage Applications and Therapeutics. Dr Schooley discusses the unique events that led to the first use of intravenous phage therapy in North America. Stay tuned to the end for an update on phage therapy and on Thomas Patterson, the patient who received the lifesaving treatment. Related Content:
- Phage Therapy’s Role in Combating Antibiotic-Resistant Pathogens
- As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest
Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection; From Thought to Text: How an Endovascular Brain-Computer Interface Could Help Patients With Severe Paralysis Communicate Related Content:
- Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection
- From Thought to Text: How an Endovascular Brain-Computer Interface Could Help Patients With Severe Paralysis Communicate
- Swab the Throat as Well as the Nose? The Debate Over the Best Way to Test for SARS-CoV-2
- Study: Short Spurts of Vigorous Physical Activity During Daily Life Are Associated With Lower Mortality
- Ceasefire Declared, but Ethiopian Health Systems Remain in Critical Condition After Civil War
Telemedicine Rollbacks—Why Providing Care Across State Lines Is No Longer as Simple as It Was Early in the Pandemic; Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic; Will the New CDC Opioid Prescribing Guidelines Help Correct the Course in Pain Care? Related Content:
- Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic
- Will the New CDC Opioid Prescribing Guidelines Help Correct the Course in Pain Care?
Trying to Predict What the COVID-19 Pandemic Might Look Like This Winter in the US; “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge; Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People.
Related Content:
- How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave
- “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge
- Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People
- Highlights From the American Heart Association’s Scientific Sessions 2022—COVID-19’s Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More
- Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio
- After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation
- Detailed Maternal Mortality Data Suggest More Than 4 in 5 Pregnancy-Related Deaths in US Are Preventable
Medical News Associate Managing Editor Jennifer Abbasi and Conference Chair Manesh Patel, MD, discuss hot trials and topics from the American Heart Association’s Scientific Sessions meeting. Patel is the Richard S. Stack Distinguished Professor and chief of cardiology at Duke University School of Medicine.
Related Content:
- Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021
- After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation
JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Adarsh Bhimraj, MD, about new research and timely topics discussed at Infectious Disease Week (IDWeek) 2022. Dr Bhimraj, who was one of the conference chairs, is also director of Infectious Diseases Fellowship and Education at Houston Methodist Hospital.
Related Content:
- Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio
Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training
Related Content:
- Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions
- Treating Cancer in Pregnant Patients After Roe v Wade Overturned
- Dobbs Decision Threatens Full Breadth of Ob-Gyn Training
In July 2022, Nahid Bhadelia, MD, MALD, joined the White House COVID-19 Response Team as senior policy advisor for Global COVID Response. The infectious disease physician, who is on sabbatical from Boston University, spoke with JAMA Associate Managing News Editor Jennifer Abbasi about the pandemic’s true burden of disease in low- and middle-income countries and ongoing COVID-19 vaccine inequity.
Related Content:
- White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations—Undercounted Deaths, Vaccine Inequity, and More
- Global COVID-19 Update (video)
New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings; Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices.
Related Content:
- New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings
- Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices
- Reports of Asymptomatic Monkeypox Suggest That, at the Very Least, Some Infections Go Unnoticed
- After the Genome—A Brief History of Proteomics
- Dr Fauci and the Art of Science Communication
- The Dreaded “Twindemic” of Influenza and COVID-19 Has Not Yet Materialized—Might This Be the Year?
The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
Related Content:
- The US Now Has a Research Plan for Long COVID—Is It Enough?
- Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
- Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
- Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise
- Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change
- Addressing the Long-term Effects of COVID-19
- Long COVID: The US Federal Response (audio)
- Long COVID: The US Federal Response (video)
The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
Related Content:
- The US Now Has a Research Plan for Long COVID—Is It Enough?
- Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
- Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
- Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise
- Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change
- Addressing the Long-term Effects of COVID-19
- Long COVID: The US Federal Response (audio)
- Long COVID: The US Federal Response (video)
How Abortion Bans Could Affect Care for Miscarriage and Infertility; COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies; Code Blue—What to Do When the Shooting Starts.
Related Content:
- COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies
- How Abortion Bans Could Affect Care for Miscarriage and Infertility
- Code Blue—What to Do When the Shooting Starts
Studies dating back to the late 1950s have shown that people with South Asian ancestry have higher cardiovascular disease risk compared with other racial and ethnic groups, and the heightened risks have been observed in the US over the past 2 decades. To better understand why, in 2010 two Indian American internists, Alka Kanaya, MD, and Namratha Kandula, MD, MPH, launched the Mediators of Atherosclerosis in South Asians Living in America, or MASALA, prospective cohort study. Drs Kanaya and Kandula spoke with JAMA Medical News Associate Managing Editor Jennifer Abbasi about cardiovascular disease and risk factors among people of South Asian descent.
Related Content:
MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks
In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.
Related Content:
- The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network
- A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video)
- A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)
The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid; What to Know About Monkeypox; UN Reports New Insights on Link Between Climate Change and Human Health.
Related Content:
- The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid
- What to Know About Monkeypox
- UN Reports New Insights on Link Between Climate Change and Human Health
JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Sonali Smith, MD, about new research and timely topics from the recent annual meeting of the American Society of Clinical Oncology (ASCO). Dr Smith, who chaired the conference’s Scientific Program Committee, is also chief of the hematology and oncology section at the University of Chicago Medicine.
Related Content:
- Highlights From the 2022 Annual Meeting of the American Society of Clinical Oncology—Disparities in Clinical Trials, Mitigating Clinician Burnout, and Combination Treatments for Cancer
- Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer
- Cancer Risk and Mortality in Adults With Obesity Who Underwent Bariatric Surgery vs No Surgery
Loren Laine, MD, professor of Medicine (Digestive Diseases); chief, Section of Digestive Diseases, Internal Medicine; medical chief, Digestive Health, Yale New Haven Health, discusses the pandemic-related decline in colorectal cancer screening, racial and ethnic disparities in cancer care and survival, and other research highlights from the recent Digestive Disease Week meeting.
Related Content:
Highlights From Digestive Disease Week—Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More
JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Andrew J. Halayko, PhD, ATSF, MSc, BSc, about some important research studies and keynote addresses presented at the American Thoracic Society (ATS) International Conference in May 2022. Dr Halayko is professor of physiology and internal medicine at the University of Manitoba in Canada and this year’s ATS conference chair.
Related Article(s):
American Thoracic Society 2022 Conference Highlights
What a Post–Roe v Wade US Might Look Like for Physicians; SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus
Related Article(s):
- What a Post–Roe v Wade US Might Look Like for Physicians
- SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus
Clinical Trials Disrupted During War in Ukraine; The Role of Supervised Consumption Sites for People Who Use Illicit Drugs
Related Content:
- Clinical Trials Disrupted During War in Ukraine
- The Role of Supervised Consumption Sites for People Who Use Illicit Drugs
Preventive cardiologist and conference cochair Pamela Morris, MD, discusses new heart failure management guidelines and important clinical trial results presented at the American College of Cardiology’s 2022 Scientific Sessions.
Related Content:
- Highlights From the American College of Cardiology’s Scientific Sessions—New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy
- Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a)
- Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis
- The Potential Clinical Benefit of Lowering Lipoprotein(a)
Physicians in Ukraine—Caring for Patients in the Middle of a War; The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks; How Cancer Will Affect the US in 2022
Related Content:
-
Physicians in Ukraine: Caring for Patients in the Middle of a War
-
The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks
-
How Cancer Will Affect the US in 2022
Russian attacks on Ukraine have created a humanitarian crisis and made the treatment of patients exponentially more difficult. Two Ukrainian doctors, Oleksandra Shchebet and Anastasiia Barzylovych, share their experiences as they practice medicine in a dangerous wartime environment. Recorded March 9, 2022.
Related Content:
Physicians in Ukraine: Caring for Patients in the Middle of a War
JAMA Medical News Senior Staff Writer Melissa Suran speaks with Louise McCullough, MD, PhD, about new research and timely topics from the American Heart Association and American Stroke Association’s annual International Stroke Conference. McCullough, who chaired this year’s conference, is also chair of neurology at the University of Texas Health Science Center at Houston and chief of neurology at Memorial Hermann—Texas Medical Center.
Related Content:
Highlights From the International Stroke Conference 2022—Thrombectomy and Alteplase, Access to Stroke Centers, and Warfarin vs Direct Oral Anticoagulants
COVID-19 and the Common Cold: Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity; When Physicians Spread Unscientific Information About COVID-19; How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic.
Related Content:
- COVID-19 and the Common Cold—Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity
- When Physicians Spread Unscientific Information About COVID-19
- How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic
Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis; RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths; Preparing Hospitals’ Medical Oxygen Delivery Systems for a Respiratory “Twindemic.”
Related Content:
- Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis
- RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths
- Preparing Hospitals’ Medical Oxygen Delivery Systems for a Respiratory “Twindemic”
Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19; COVID-19 Vaccine Makers Plan for Annual Boosters, but It’s Not Clear They’ll Be Needed; Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
Related Content:
- Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19
- The Debate Over Whether Repeated COVID-19 Boosters Will Be Needed
- Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19
JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with physician-geneticist Francis S. Collins, MD, PhD, as he steps down as director of the National Institutes of Health (NIH) and returns full-time to his laboratory at the National Human Genome Research Institute. Collins discusses the NIH’s biggest accomplishments and challenges during his historic tenure, shares what he will and won’t miss about the job, and much more.
Related Content:
After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity, Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis, Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents.
Related Article(s):
- The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity
- Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis
- Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents
JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with Manesh Patel, MD, about the latest trials and topics from the American Heart Association’s Scientific Sessions meeting. Patel is chief of the division of cardiology at Duke University School of Medicine and this year’s Scientific Sessions conference chair.
Related Content:
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
- Highlights From the American Heart Association’s Scientific Sessions—ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, Aspirin and Dementia, and More
Authors have declared conflicts of interest related to the article discussed in this podcast. Visit the article on jama.com for the complete disclosure.
COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound
Related Content:
- COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
- COVID-19 Testing Moves Out of the Clinic and Into the Home
- The Lingua Franca of Addiction—Stigmatizing Words That Wound
The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford Foundation in New York City, discusses the challenges skilled nursing facilities face and shares her vision for nursing homes that better serve residents and support the workforce.
Related Content:
- COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
- Socially Assistive Robots Help Patients Make Behavioral Changes
After Mildest Flu Season Ever, Influenza Experts Wonder What Comes Next; Why Farmworkers Need More Than New Laws for Protection From Heat-Related Illness; COVID-19 Sets Back Efforts to See the Person in the ICU Patient
Related Content:
- After Mildest Flu Season Ever, Influenza Experts Wonder What Comes Next
- Why Farmworkers Need More Than New Laws for Protection From Heat-Related Illness
- How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals
Many patients experience neurocognitive deficits, PTSD, and generalized weakness and disability following an intensive care unit (ICU) stay. JAMA Medical News Senior Writer Rita Rubin talks with E. Wesley Ely, MD, MPH, a professor of medicine at Vanderbilt University School of Medicine, about ICU aftereffects, post-acute COVID-19 syndrome, and how the coronavirus pandemic, particularly hospitals’ restrictions on visitors, impeded progress made since the 1990s in caring for the critically ill.
Related Content:
How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals
More than half of the 80 000 emergency personnel, volunteers, and recovery and cleanup workers known to have responded to the September 11, 2001, terrorist attacks at the World Trade Center, the Pentagon, and the crash site near Shanksville, Pennsylvania, have at least 1 certified physical or mental health condition related to their exposures. First responder Terrence Jordan, a retired lieutenant with the Fire Department of the City of New York, shares his story.
Related Content:
- Twenty Years After 9/11, Responders Are Still Healing
- 9/11 Responders’ Health 20 Years Later, Part 1
More than half of the 80 000 emergency personnel, volunteers, and recovery and cleanup workers known to have responded to the September 11, 2001, terrorist attacks at the World Trade Center, the Pentagon, and the crash site near Shanksville, Pennsylvania, have at least 1 certified physical or mental health condition related to their exposures. Pulmonologist David Prezant, MD, chief medical officer for the Fire Department of the City of New York and a professor of medicine at Albert Einstein College of Medicine in the Bronx, shares his 9/11 story and updates us on how the responders are doing 20 years after the events.
Related Content:
- Twenty Years After 9/11, Responders Are Still Healing
- 9/11 Responders’ Health 20 Years Later, Part 2
FDA’s Approval of New Alzheimer Drug Raises Many Questions; Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines; Detecting Kids’ Broken Hearts—Cardiac Screening Advised During Well-Child Visits
Related Content:
- Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered
- Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines
- Detecting Kids’ Broken Hearts—Cardiac Screening Advised During Well-Child Visits
The Search for a Single Vaccine Against Coronaviruses Yet to Come; Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment; Confronting High HIV Rates Among Transgender Women With Empowerment and Gender Affirmation.
Related Content:
- The Search for a Single Vaccine Against Coronaviruses Yet to Come
- Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment
- Confronting High HIV Rates Among Transgender Women With Empowerment and Gender Affirmation
Community-Based Organizations Step Up to Confront HIV in Southern States; Restrictive Policies Threaten Efforts to Stop 2 West Virginia HIV Outbreaks; Cystic Fibrosis Affects People of All Colors, Not Just Those Who Are White
Related Content:
- Community-Based Organizations Step Up to Confront HIV in Southern States
- Restrictive Policies Threaten Efforts to Stop 2 West Virginia HIV Outbreaks
- Cystic Fibrosis Affects People of All Colors, Not Just Those Who Are White
Lung transplantation has become an option of last resort for a small subset of patients with COVID-19-related acute respiratory distress syndrome (ARDS) or pulmonary fibrosis. Ankit Bharat, MD, chief of Thoracic Surgery and director of Lung Transplant and ECMO at Northwestern Memorial Hospital in Chicago, discusses his experience performing lung transplants for patients with respiratory failure due to COVID-19, including the first successful double lung transplant in the US for a patient with COVID-19-related ARDS.
Related Content:
Lung Transplants for COVID-19—The Option of Last Resort
Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants; An Inside Look at a Post–COVID-19 Clinic; COVID-19 and the “Lost Year” for Smokers Trying to Quit
Related Content:
- Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants
- An Inside Look at a Post–COVID-19 Clinic
- COVID-19 and the “Lost Year” for Smokers Trying to Quit
Michigan public officials’ decision to change Flint’s water supply in 2014 created widespread lead contamination in the city’s drinking water. Pediatrician Mona Hanna-Attisha, MD, MPH, revealed the tainted water’s effects on the city’s children during an unusual press conference in 2015. Although it took 7 years, a grand jury handed down indictments against 9 public officials, including Governor Rick Snyder, for their roles in the crisis. JAMA Medical News Associate Managing Editor Jennifer Abbasi recently caught up with Hanna-Attisha to discuss the health of Flint’s children, the future of its water supply, and other pressing public health issues.
Related Content:
Lead, Mistrust, and Trauma—Whistleblowing Pediatrician Discusses the Legacy of Flint’s Water Crisis
COVID-19 leaves some people with a troubling constellation of symptoms that has been known as long-haul COVID but now has a more formal name: postacute sequelae of SARS-CoV-2 infection (PASC). Currently, 33 states in the US have at least 1 clinic dedicated to caring for patients with PASC. Aluko Hope, MD, a pulmonary and critical care physician, cofounded the Montefiore-Einstein COVID-19 Recovery Clinic in New York in 2020. Now the medical director of the Long Covid-19 Program at the Oregon Health & Sciences University, Dr Hope provides insight into the care provided at a post-COVID-19 clinic.
Related Content:
An Inside Look at a Post–COVID-19 Clinic
In this Medical News podcast, Rita Rubin interviews retired neurologist Daniel Gibbs, MD, about his efforts to lessen the stigma surrounding Alzheimer disease, which he was diagnosed with 5 years ago.
Related Content:
Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease
How Sharing Clinical Notes Affects the Patient-Physician Relationship; Experts Discuss COVID-19—Variants and Vaccine Efficacy, Immunosuppressed Patients, and More; The Push for Timely Follow-up After Abnormal At-home Colon Cancer Screening Results
Related Content:
How Sharing Clinical Notes Affects the Patient-Physician Relationship
Experts Discuss COVID-19—Variants and Vaccine Efficacy, Immunosuppressed Patients, and More
The Push for Timely Follow-up After Abnormal At-home Colon Cancer Screening Results
In this Medical News article, William Pettit, DO, dean of the new Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation, discusses how the first US medical school on tribal land came into being.
Related Article(s):
A Partnership With the Cherokee Nation Advances Medical Education on Tribal Land
The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials; When the Human Voice Speaks Volumes About Lung Function; COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
Related Articles:
The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials
When the Human Voice Speaks Volumes About Lung Function
COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
Researchers Investigate What COVID-19 Does to the Heart; “Important Conversations” Are Needed to Explain the Nocebo Effect; Therapists Donate Their Time to Counsel Distressed Health Care Workers
Related Article:
Researchers Investigate What COVID-19 Does to the Heart
“Important Conversations” Are Needed to Explain the Nocebo Effect
Therapists Donate Their Time to Counsel Distressed Health Care Workers
Pandemic Spotlights In-home Colon Cancer Screening Tests; Does Vitamin D Deficiency Raise COVID-19 Risk?; COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients’ Misinformation
Related Article(s):
- Pandemic Spotlights In-home Colon Cancer Screening Tests
- Does Vitamin D Deficiency Raise COVID-19 Risk?
- COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients’ Misinformation
The COVID-19 pandemic has presented new challenges to people experiencing homelessness because they can't easily practice mitigation measures such as frequent handwashing and social distancing. Jennifer Tan, MD, a Massachusetts General Hospital dermatologist who has been caring for Boston's homeless population for several years, helped assemble special care kits, which included hand sanitizer and masks as well as over-the-counter treatments for skin problems, for distribution in Boston and Portland, Maine.
Communication science expert Brian Southwell, PhD, recently launched a training workshop at the Duke University School of Medicine to address a major clinical problem: What should physicians do when patients are misinformed about their health? It’s one of only a few such programs in the nation. Southwell, a scholar with the medical school’s Social Science Research Institute and a senior director at the independent, nonprofit research institute RTI International, chatted with JAMA Medical News Associate Managing Editor Jennifer Abbasi about the viral spread of false health information and malicious disinformation campaigns, why we’re vulnerable to falling for them, and how time-pressed physicians can deal with all the noise.
Related Article(s):
COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients’ Misinformation
JAMA Network Articles of the Year 2020; Looking to Long-term Survivors for Improved Pancreatic Cancer Treatment; Musical Spine Surgeons Lift Spirits With Songs of Hope
Related Article(s):
JAMA Network Articles of the Year 2020
Looking to Long-term Survivors for Improved Pancreatic Cancer Treatment
Musical Spine Surgeons Lift Spirits With Songs of Hope
Ala Stanford, MD, founder of Philadelphia's Black Doctors COVID-19 Consortium, talks with JAMA Medical News staff writer Mary Chris Jaklevic about her work to establish COVID-19 testing sites for the city's Black residents.
Related Article:
Surgeon Fills COVID-19 Testing Gap in Philadelphia’s Black Neighborhoods
JAMA sat down with Elvis Francois and William Robinson to talk about their unexpected fame as a musical duo. Videos of the 2 performing uplifting songs, with Francois on vocals and Robinson on the piano, have gone viral, leading the 2 spine surgery fellows to record an EP at a Nashville studio this past spring. They're donating all the proceeds from the successful EP to COVID-19-related charities.
Related Article:
Musical Spine Surgeons Lift Spirits With Songs of Hope
Could Frequent Testing Help Squelch COVID-19?; Nursing Homes’ Next Test—Vaccinating Workers Against COVID-19; SARS-CoV-2 Testing Hesitancy Could Hamper Mitigation Efforts
Related Articles:
The Challenges of Expanding Rapid Tests to Curb COVID-19
Nursing Homes’ Next Test—Vaccinating Workers Against COVID-19
First It Was Masks; Now Some Refuse Testing for SARS-CoV-2
JAMA Medical News comes to you live from the American Heart Association’s first-ever virtual Scientific Sessions conference. Host Jennifer Abbasi chats with conference chair and AHA president-elect Donald Lloyd-Jones, MD, ScM, about this year’s hottest clinical trials and themes: fish oil vs corn oil placebo for primary or secondary prevention; Polycap polypill with or without aspirin for primary prevention; statins, side effects, and the nocebo effect; ferric carboxymaltose iron infusion in acute heart failure; omecamtiv mecarbil, a novel cardiac myosin activator, in HFrEF; sotagliflozin, an SGLT2/1 inhibitor, in diabetes with recent worsening heart failure or in diabetes and chronic kidney disease; MINOCA’s underlying cause in women; rilonacept, an IL-1α and IL-1β Trap, in recurrent pericarditis; COVID-19’s cardiovascular effects, risk factors, and racial/ethnic disparities.
Related article:
Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks; As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts; Telephone Visits Surge During the Pandemic, but Will They Last?
Related articles:
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks
As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts
Telephone Visits Surge During the Pandemic, but Will They Last?
University of North Carolina (UNC) at Chapel Hill nutrition scholar Barry Popkin, PhD, and JAMA Medical News Associate Managing Editor Jennifer Abbasi discuss new findings on obesity and COVID-19. Popkin is the lead author of a systematic review and meta-analysis on the topic that was published recently in Obesity Reviews. He is a distinguished professor in the department of nutrition at the UNC Gillings School of Global Public Health.
Related Article(s):
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks
What Happens When COVID-19 Collides With Flu Season?; Flu Vaccination Urged During COVID-19 Pandemic; COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Related Article(s):
What Happens When COVID-19 Collides With Flu Season?
Flu Vaccination Urged During COVID-19 Pandemic
COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Science communications expert Dominique Brossard, PhD, and JAMA Medical News Associate Managing Editor Jennifer Abbasi discuss research-based strategies to encourage mask wearing, social distancing, and hand washing during the COVID-19 pandemic. Dr. Brossard is a professor and chair of the Department of Life Sciences Communication at the University of Wisconsin-Madison and part of a new COVID-19-focused National Academies of Science, Engineering, and Medicine group.
Related Article(s):
The Science of Persuasion Offers Lessons for COVID-19 Prevention
Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials; Taking a Closer Look at COVID-19, Health Inequities, and Racism; From Auto Mechanic to Emergency Medicine Resident: Inspiring Young Blacks to Become Physicians
Related articles:
Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials
Taking a Closer Look at COVID-19, Health Inequities, and Racism
From Auto Mechanic to Emergency Medicine Resident: Inspiring Young Blacks to Become Physicians
Carl Allamby, MD, discusses his circuitous route from long-time auto repair shop owner to emergency medicine resident with JAMA Medical News Senior Writer Rita Rubin. Growing up in Cleveland, Allamby never saw physicians who looked like him, but an introductory biology course required for his undergraduate business degree sparked a long dormant dream of becoming a physician.
Related Article(s):
From Auto Mechanic to Emergency Medicine Resident: Inspiring Young Blacks to Become Physicians
School Superintendents Confront COVID-19—“There Are No Good Options for Next Year”; Social Isolation—the Other COVID-19 Threat in Nursing Homes; COVID-19’s Lasting Impact on Medical Practices
Related articles:
COVID-19’s Crushing Effects on Medical Practices, Some of Which Might Not Survive
School Superintendents Confront COVID-19—“There Are No Good Options for Next Year”
Social Isolation—the Other COVID-19 Threat in Nursing Homes
Chicago public health legend and retired physician Linda Rae Murray, MD, discusses systemic racism and the pandemic’s disproportionate effect among African Americans and other people of color with JAMA Medical News Associate Managing Editor Jennifer Abbasi. Dr Murray is an adjunct assistant professor at the University of Illinois at Chicago School of Public Health and a past president of the American Public Health Association.
Related:
Taking a Closer Look at COVID-19, Health Inequities, and Racism
Latin America and Its Global Partners Toil to Procure Medical Supplies as COVID-19 Pushes the Region to Its Limit; “Abandoned” Nursing Homes Continue to Face Critical Supply and Staff Shortages as COVID-19 Toll Has Mounted; Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development?
Article links:
Latin America and Its Global Partners Toil to Procure Medical Supplies as COVID-19 Pushes the Region to Its Limit
“Abandoned” Nursing Homes Continue to Face Critical Supply and Staff Shortages as COVID-19 Toll Has Mounted
Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development?
JAMA's Angel Desai, MD, speaks with Gary Marcus, PhD, coauthor of Rebooting AI: Building Artificial Intelligence We Can Trust. Marcus argues that endowing machines with intelligence will require innovation that embraces the complexity of the real world. Plus: How can AI be used during COVID-19?
Related:
Artificial Intelligence: Promise, Pitfalls, and Perspective
Convalescent Plasma for COVID-19; Prioritizing Physician Mental Health as COVID-19 Marches On; Global Effort to Collect Data on Ventilated Patients With COVID-19
The University of New Mexico's Eileen Barrett, MD, MPH, speaks with JAMA's Jennifer Abbasi about the pandemic's mental and emotional toll on health care workers—and how they and their employers can safeguard their well-being.
Read the Article: Prioritizing Physician Mental Health as COVID-19 Marches On
Finding Ways to Reduce Coronavirus Exposure During Dialysis; The Promise and Peril of Antibody Testing for COVID-19; The Challenge of Preventing COVID-19 Spread in Correctional Facilities
A new exhibit on the 1918 flu pandemic asks: What is an individual's responsibility to their community during a pandemic? Exhibit curator Jane Boyd and museum manager Nancy Hill take Jennifer Abbasi on a tour of the medical museum's new exhibit just weeks before the COVID-19 outbreak first emerged.
Pandemic Part 1: 1918 Flu Pandemic and COVID-19
Read the article:
Twentieth-Century Lessons for a Modern Coronavirus Pandemic
Medical historian Howard Markel, MD, PhD, director of the University of Michigan's Center for the History of Medicine, speaks with JAMA Fishbein fellow Angel Desai, MD, about lessons from the devastating 1918 flu pandemic. Markel discusses his research into the effects of social distancing on US death rates during the worldwide outbreak.
Pandemic Part 2: A Trip to Philadelphia’s Mutter Museum
Read the article:
Twentieth-Century Lessons for a Modern Coronavirus Pandemic
David Strauss, MD, PhD, of the FDA talks with Jennifer Abbasi about his recent studies in JAMA investigating sunscreen safety
Related:
FDA Trials Find Sunscreen Ingredients in Blood, but Risk Is Uncertain
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial
Fixing the Parent Trap for Resident Physicians; Confirmatory Trial For Drug to Prevent Preterm Birth Finds No Benefit, So Why Is It Still Prescribed?; The Low-FODMAP Diet Helps IBS Symptoms, but Questions Remain
Taking Medicine to the Streets to Care for Those Who Live There; Trauma-Informed Care May Ease Patient Fear, Clinician Burnout
The 2019 novel coronavirus (2019-nCoV) outbreak exemplifies ongoing biothreats to global security, as each new threat tests principles of preparation and response at national, regional, and clinical levels. Tom Inglesby, MD, director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, discusses biosecurity with Angel Desai, MD, JAMA Fishbein fellow.
Alzheimer Disease and Brain Glucose Metabolism, Testosterone for Postmenopausal Low Sexual Desire, Concussions and Erectile Dysfunction Among Football Players
JAMA Network Articles of the Year 2019, Cannabidiol Products, Heritage Diets and Culturally Appropriate Dietary Advice, Cancer Risk Among People With Psoriasis
Firearms and Dementia, New Center for Psychedelic Research, Older Patients in Cancer Clinical Trials, Knowledge Gaps in Type 2 Diabetes Prevention, Universal Flu Vaccine and More in Medical News.
JAMA Medical News is coming to you live from the American Heart Association’s Scientific Sessions conference in Philadelphia. In this episode, host Jennifer Abbasi interviews Stanford University’s Christopher Gardner, PhD, about the nutrition consensus and controversies discussed at this year’s meeting. When it comes to salt, eggs, dairy, and meat, what can we agree on and where do we still have to agree to disagree?
JAMA AHA 2019 Scientific Sessions Website
JAMA Medical News is coming to you live from the American Heart Association’s Scientific Sessions conference in Philadelphia. This year’s conference included a timely topic: the e-cigarette epidemic in youth. Host Jennifer Abbasi interviews Rose Marie Robertson, MD, the AHA’s deputy chief science and medical officer, about the latest epidemiological data, what the science says about e-cigarettes, and what the AHA is doing to counter the vaping trend in youth.
Related article: e-Cigarette Use Among Youth in the United States, 2019
JAMA AHA 2019 Scientific Sessions Website
JAMA Medical News is coming to you live from the American Heart Association’s Scientific Sessions conference in Philadelphia. In this episode, host Jennifer Abbasi chats with conference chair Donald Lloyd-Jones, MD, ScM, about this year's hottest topics and clinical trials.
JAMA AHA 2019 Scientific Sessions Website
In this Medical News podcast, Rita Rubin speaks with Roland Griffiths, PhD, about the use of psychedelics as potential therapies for neurological and mental health disorders and to better understand the mind.
Read the article: Philanthropists Fund Johns Hopkins Center for Study of Psychedelics
Biomarker-Based PTSD Screening, Cardiovascular Corner, Stopping Cancer Screening in Older Adults, Subconcussive Football Hits, Easing Contraceptive Access, Prescription Drug Costs, and More in Medical News.
In this Medical News podcast, Rebecca Voelker speaks with emergency physician Emmy Betz, MD, MPH, about safety issues concerning people with dementia who own or live in a home with firearms.
Studying the Adolescent Brain, A New form of Dementia, Advances in Type 1 Diabetes Research, Telemedicine for Opioid Use Disorder, Vacations and Metabolic Syndrome, Modest Calorie Reduction for Cardiometabolic Health, and More in JAMA Medical News.
Cardiac Rehab, 13 Reasons Why and Youth Suicides, Peanut Oral Immunotherapy, Social Media and Medicine, Herpes Zoster Opthalmica, Mindfulness for Surgeons, Steps and Mortality and More in JAMA Medical News.
In this Medical News podcast, Jennifer Abbasi discusses recent advances in type 1 diabetes with Yale’s Kevan Herold, MD, and gets a patient perspective on the illness.
In this Medical News podcast, Jennifer Abbasi interviews the director of the ABCD study, Gaya Dowling, PhD, about this long-term study of brain development and child health in the United States.
This Medical News podcast discusses the value of social media for health care.
Read the article: Getting Social: Physicians Can Counteract Misinformation With an Online Presence
Scam Awareness and Dementia Risk, Cardiovascular Corner, Wild Health, Palliative Care Practices, Talking About Death, Vitamin C Drug Cocktail for Sepsis, Appendix and Parkinson Disease Risk, and More in JAMA Medical News.
This Medical News podcast discusses how all physicians who treat seriously ill patients can integrate palliative care into their practices.
Read the article: New Guidelines Aim to Expand Palliative Care Beyond Specialists
Opioid Prescribing Limits, TMAO and Heart Disease, Diversity in Public Health Schools, Sufentanil for the Battlefield, Menthol Cigarettes, Catch-up Sleep, Interval Training for Fat Loss, 'Broken Heart' Syndrome, and More in JAMA Medical News.
Q & A with Patricia Boyle, PhD: Susceptibility to Scammers Might Signify Increased Risk of Dementia
Read the article: Low Awareness of Scammers’ Tactics Linked to Dementia Risk in Cognitively Normal People
High Fiber Diet Benefits, Arts and Medical Education, Skipping Breakfast, Wilderness Medicine, Eggs and CVD, Multiple Symptoms in Older Adults, Allergenic Inactive Ingredients, and more in JAMA Medical News.
In this Medical News podcast, Jennifer Abbasi speaks with the author of a recent study in JAMA that looked at the association between dietary cholesterol and cardiovascular disease.
US Maternal Mortality, Nonsugar Sweetened Beverages and Stroke, Mesh Implants, Rotavirus Vaccine and Type-1 Diabetes, Childhood Lead Exposure, BRCA Exchange, Consumer Chemicals and Early Puberty, and more in JAMA Medical News. View related article here.
In this Medical News podcast, Jennifer Abbasi interviews Yasmin Mossavar-Rahmani, PhD, RD, who studied the association of artificially sweetened beverages with cardiovascular disease and mortality in women.
See related article.
In this Medical News podcast, Rita Rubin interviews the second woman physician to serve in US Congress.
Housing programs for the homeless, glioblastoma sex differences, medicine’s weight bias, nonsugar sweeteners and health, post–intensive care syndrome, adult food allergies, eczema in the elderly, and more in JAMA Medical News.
In this Medical News podcast, an emergency physician describes his experiences during last November's Camp Fire, one California's worst wildfires.
Read the article: Paradise’s Emergency Department Director Recalls California’s Worst Wildfire
AAP's Statement on Corporal Punishment, Eating Insects, New President of Planned Parenthood, Questioning Probiotics, Congenital Syphilis, New Cholesterol Guidelines, and more in JAMA Medical News.
Black Lung Disease Resurgence, Nobel Peace Prize Winner's Patients Inspire, "This Is Our Lane", Advancements in Cancer Immunotherapy, Harassment and Assault and Women's Health, Curbing the Swelling Tide of STIs, and more in Medical News.
In this Medical News podcast, Jennifer Abbasi interviews Leana Wen, MD, the new president of Planned Parenthood.
In this Medical News Podcast, Jennifer Abbasi interviews Robert Sege, MD, PhD, coauthor of the recent American Academy of Pediatrics policy statement on corporal punishment for children.
In this Medical News podcast, Jennifer Abbasi interviews Rebecca Thurston, PhD, about her recent study published in JAMA Internal Medicine, which found that sexual harassment and assault were associated with poorer midlife health in women.
Read the articles discussed in this podcast: Association of Sexual Harassment and Sexual Assault With Midlife Women’s Mental and Physical Health and Internet Searches for Sexual Harassment and Assault, Reporting, and Training Since the #MeToo Movement.
Feyza Sancar, PhD, Director of JAMA Medical News, summarizes news content appearing in the December 2018 issues of JAMA.
In this Medical News podcast, Rita Rubin interviews Megan Ranney, MD, MPH, one of the leading voices in the “This Is Our Lane” movement, discussing the role of physicians and other health care professionals in addressing firearm violence as a public health issue.
In this Medical News podcast, Rita Rubin interviews Dr. Denis Mukwege, cowinner of the 2018 Nobel Peace Prize.
Read the article: For Nobel Peace Prize Winner Dr. Denis Mukwege, His Patients Motivate and Inspire
In this Medical News podcast, Rita Rubin interviews the director of the National Institute of Child Health and Human Development about its Human Placenta Project.
Read the article: Unraveling the Mysteries of the Human Placenta
Feyza Sancar, PhD, Director of JAMA Medical News & Perspectives, summarizes news content appearing in the November 2018 issues of JAMA.
This Medical News podcast discusses brain organoids, their research and clinical potential and ethical implications.
In this Medical News podcast, Rita Rubin interviews the founders of One Tent Health, a nonprofit free HIV screening initiative that serves high-risk neighborhoods in Washington, DC.
In this Medical News podcast, infectious disease threats expert Michael Osterholm, PhD, MPH, discusses how the United States and the rest of the world may fare if another 1918-like influenza epidemic strikes.
Beef and poultry grown from animal cells rather than sourced from whole animals could be the future of meat production, a cardiologist-turned-biotech entrepreneur says in this Medical News podcast.
In this Medical News Podcast, Dr. Myriam Allende-Vigo, an endocrinologist practicing in Humacao, Puerto Rico, talks about her experiences caring for patients during and after last year's devastating storm.
In this Medical News podcast, Jennifer Abbasi speaks with Dr Anthony Fauci about the progress and future goals toward eliminating HIV/AIDS.
In this Medical News podcast, frequent traveler Rachel Zang, MD, talks about her experiences helping ill patients aboard commercial airline flights and discusses what physicians should know about in-flight medical emergencies.
Read the article: "Is There a Doctor on the Plane?"
In this Medical News podcast, Jennifer Abbasi speaks with Dr. Adam Gazzaley about his work developing a video game-based therapy for pediatric attention-deficit/hyperactivity disorder.
Read the article: Adam Gazzaley, MD, PhD: Developing Prescribable Video Games
In this Medical News Podcast, Rebecca Voelker interviews Daniel Levy, MD, director of the Framingham Heart Study, about women's participation during the study's 70-year history.
In this Medical News Podcast, Jennifer Abbasi interviews cardiologist Stephen Devries, MD, about an institute that educates doctors about healthful eating. View article here
In this Medical News podcast, Jennifer Abbasi interviews Yale University professor Robert Kerns, PhD, about nondrug approaches to pain management and the National Institutes of Health-Department of Defense-Veterans Affairs pain management collaboration.
Read the article: Robert Kerns, PhD: Researching Nondrug Approaches to Pain Management
In this Medical News podcast, JAMA Associate Editor Christopher Muth, MD, discusses the use of antisense oligonucleotide therapies for treatment of neurological diseases with Stefan Pulst, MD, Chairman of Neurology at the University of Utah.
Interview with Shantanu Nundy, MD, about a new way for physicians to collaborate on cases online.
Read the article: Shantanu Nundy, MD: The Human Diagnosis Project
This Medical News podcast discusses recent advances in therapeutic treatments for multiple sclerosis.
In this Medical News podcast, we discuss the use of ketamine and ketamine-like agents for treatment-resistant depression with psychiatrist Carlos A. Zarate Jr, MD.
This Medical News podcast discusses how bacteriophage therapy might help fight antibiotic-resistant infections.
This podcast discusses an international project to map all cell types and states in the human body.
This podcast discusses the development of socially assistive robots for patient rehabilitation and training. Related article: Socially Assistive Robots Help Patients Make Behavioral Changes
This podcast discusses the latest research into the workings of the lung microbiome and how it will affect future diagnosis and treatment of respiratory diseases. Related article: The Lung Microbiome: Key to Respiratory Ills?
This Medical News podcast features an interview with Barry Marshall, MD, who codiscovered the stomach bug H pylori in 1982.
Rudolph Tanzi, PhD, of Harvard University, and Berislav Zlokovic, MD, PhD, of the University of Southern California, discuss what the future holds for Alzheimer Disease research and treatment.
In this Medical News podcast, Jennifer Abbasi interviews Nutrition Research Task Force chair Griffin P. Rodgers, MD, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the NIH.
Read the article: NIH Charts a Path for Nutrition Science
This Medical News podcast discusses the Human Genome Project-write with Harvard geneticist, George Church, PhD.
This Medical News podcast features a Q&A with CDC Director Tom Frieden, MD, commemorating the agency’s historic 70th anniversary. The interview was recorded on August 8th, 2016.
Interview with Barbara E. Murray, MD, author of Infectious Disease Expert Sees Threat From Colistin-Resistant Superbug
Interview with Dorry Segev, MD, PhD, author of HIV and Transplantation: New Reasons for HOPE
Christine Curry, MD, PhD, assistant professor of obstetrics and gynecology at the University of Miami, discusses the challenges of keeping pregnant patients and her colleagues well-informed of the facts as Zika virus fears circulate.
Adi Nadimpalli, MD, the Doctors Without Borders/Médecins Sans Frontières (MSF) Head of Mission in Nepal, and the former vice president of the US board of directors, talks about MSF’s mission and the challenges he has faced serving in countries where access to health care is insufficient or strained due to natural or manmade disasters, violent conflicts, epidemics, and population displacement.
Harold Varmus, MD, former director of the National Cancer Institute, talks about his career and his ideas for improving the biomedical research enterprise.